financetom
CRI
financetom
/
Consumer Discretionary
/
CRI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Carter's, Inc.CRI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Carter's, Inc., together with its subsidiaries, designs, sources, and markets branded childrenswear under the Carter's, OshKosh, Skip Hop, Child of Mine, Just One You, Simple Joys, little planet, and other brands in the United States and internationally.

The company operates through three segments: U.S. Retail, U.S. Wholesale, and International. Its Carter's products include babies and young children products, such as bodysuits, pants, dresses, layette essentials, tops and t-shirts, multi-piece sets, sleep and play products, and sleepwear; and OshKosh brand products comprise playclothes, such as denim apparel products, overalls, core bottoms, knit tops, t-shirts, and layering pieces.

The company also provides products for playtime, travel, mealtime, bath time, and home gear, as well as kid's bags under the Skip Hop brand.

In addition, it offers bedding, home décor, cribs and baby furniture, diaper bags, footwear, gift sets, hair accessories, jewelry, outerwear, paper goods, socks, shoes, swimwear, and toys.

The company operates wholesale locations, including department stores, national chain stores, and specialty stores, as well as retail stores.

It also sells its products through its eCommerce websites, such as carters.com, oshkosh.com, and skiphop.com, as well as other international wholesale accounts and licensees.

The company was founded in 1865 and is headquartered in Atlanta, Georgia.

Latest News >
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Jul 3, 2024
In a significant development in the battle against Alzheimer’s disease, the U.S. Food and Drug Administration (FDA) has approved Eli Lilly ( LLY ) and Company’s Alzheimer’s treatment, “Kisunla.” What Happened: As per the official press release on Tuesday, Kisunla (donanemab-azbt), a once-monthly IV infusion injection, is intended for adults in the early symptomatic stages of Alzheimer’s disease, including those...
China leading generative AI patents race, UN report says
China leading generative AI patents race, UN report says
Jul 3, 2024
GENEVA, July 3 (Reuters) - China is far ahead of other countries in generative AI inventions like chatbots, filing six times more patents than its closest rival the United States, U.N. data showed on Wednesday. Generative AI, which produces text, images, computer code and even music from existing information, is exploding with more than 50,000 patent applications filed in the...
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval
Jul 3, 2024
04:15 AM EDT, 07/03/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Wednesday the European Commission has approved Dupixent as an additional maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, or COPD, a respiratory disease that damages the lungs. The decision marks the first Dupixent approval worldwide for COPD patients, the companies...
Futu's Wealth Business Surpasses $10 Billion in Assets Under Management
Futu's Wealth Business Surpasses $10 Billion in Assets Under Management
Jul 3, 2024
04:16 AM EDT, 07/03/2024 (MT Newswires) -- Futu Holdings ( FUTU ) said early Wednesday its wealth management business surpassed $10 billion in assets under management. The company also said its fully-owned subsidiary, Moomoo Securities Malaysia, recently received approval from the Federation of Investment Managers Malaysia to distribute wealth management products in the country. Price: 65.89, Change: -0.13, Percent Change:...
Copyright 2023-2025 - www.financetom.com All Rights Reserved